Journals / Turkish Journal of Gastroenterology / 2022 / Cilt: 33 - Sayı: 2

Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations

Pages
81–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However more studies are needed to reveal the exact frequency of these variations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Familial adenomatous polyposis (OMIM #175100) and MUTYH-associated polyposis (OMIM #608456) are rare cancerprone disorders characterized by hundreds of adenomatous polyps in the colon and rectum, which have a high probability of malignant transformation.
📊
Key Findings & Data:Attenuated familial adenomatous polyposis is a variant of familial adenomatous polyposis, which is a term used for the condition in which patients have less than 100 colorectal polyps.
💡
Conclusion & Impact:However more studies are needed to reveal the exact frequency of these variations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: Familial adenomatous polyposis (OMIM #175100) and MUTYH-associated polyposis (OMIM #608456) are rare cancerprone disorders characterized by hundreds of adenomatous polyps in the colon and rectum, which have a high probability of malignant transformation. Attenuated familial adenomatous polyposis is a variant of familial adenomatous polyposis, which is a term used for the condition in which patients have less than 100 colorectal polyps. Germline heterozygous Adenomatous polyposis coli (APC) and biallelic MUTYH (mutY DNA glycosylase) pathogenic variations are responsible for familial adenomatous polyposis and MUTYH-associated polyposis respectively. The aim of this study is to discuss the clinical manifestations of patients having pathogenic APC and MUTYH variations. Methods: We included 27 probands who have more than 10 colonic polyps in this study. After evaluation of their clinical and family histories, the probands were screened for APC and MUTYH variations via next generation sequencing. The family members of the probands carrying pathogenic variations were screened via Sanger sequencing. Results: Among 27 probands, pathogenic APC and MUTYH variations were detected in 3 and 6 probands respectively. In the APC gene, 3 novel truncating variations (p.Leu360*, p.Leu1489Phefs*23, and p.Leu912*) were detected in 3 unrelated probands. In the MUTYH gene, only 2 distinct pathogenic variations were detected (p.Pro295Leu and p.Glu480del) in the homozygous or compound heterozygous state. Conclusion: In this study, molecular etiology was clarified in 9 familial polyposis patients. The p.Pro295Leu and p.Glu480del variations seem to be common in the Turkish population and may be considered as a first-step genetic test in Turkish familial polyposis patients showing autosomal recessive inheritance. However more studies are needed to reveal the exact frequency of these variations.

🔖

Cite This Article

ATEŞ, E. A., ALAVANDA, C., DEMİR, Ş., KEKLİKKİRAN, C., ATTAALLAH, W., ÖZDOĞAN, O. C., GÜNEY, A. İ. (2022). Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations. Turkish Journal of Gastroenterology, Cilt: 33 - Sayı: 2, 81–87. https://ajindex.com/articles/411637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006
  2. 101(2):385-398. [CrossRef] 2. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001
  3. 10(7):721-733. [CrossRef] 3. Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 1994
  4. 3(2):121-125. [CrossRef] 4. Mazzei F, Viel A, Bignami M. Role of MUTYH in human cancer. Mutat Res. 2013
  5. [CrossRef] 5. Win AK, Jenkins MA, Dowty JG, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2017
  6. 26(3):404-412. [CrossRef] 6. Sutcliffe EG, Thompson AB, Stettner AR, et al. Multi-gene panel testing confirms phenotypic variability in MUTYH-associated polyposis. Fam Cancer. 2019
  7. 18(2):203-209. [CrossRef] 7. Curia MC, Catalano T, Aceto GM. MUTYH: not just polyposis. World J Clin Oncol. 2020
  8. 11(7):428-449. [CrossRef] 8. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015
  9. 17(5):405- 424. [CrossRef] 9. Gayther SA, Wells D, SenGupta SB, et al. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet. 1994
  10. 3(1):53-56. [CrossRef] 10. de Marchis ML, Tonelli F, Quaresmini D, et al. Desmoid tumors in familial adenomatous polyposis. Anticancer Res. 2017
  11. 37(7):3357- 3366. [CrossRef] 11. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993
  12. 75(5):951-957. [CrossRef] 12. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet. 2002
  13. 11(23):2961-2967. [CrossRef] 13. Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006
  14. 119(4):807- 814. [CrossRef] 14. Lejeune S, Guillemot F, Triboulet JP, et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat. 2006
  15. 27(10):1064. [CrossRef] 15. Colas C, Bonadona V, Baert-Desurmont S, et al. MUTYH-associated polyposis: review a